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INTRODUCTION
The quantification of population health plays an 
important role in decision making processes within the 
health sector. Burden of disease is a measure of the gap 
between current health status and an ideal situation 
where everyone lives into old age free from disease and 
disability.Supported by the World Bank and the World 
Health Organization (WHO), the Disability-Adjusted Life 
Year or DALY has emerged as the most important disease 
burden metric, combining life years lived in less-than-
perfect health and life years lost due to mortality.1,2 
By expressing the burden of disease as a single metric, 
comparing the relative impact ofdifferent diseases is 
facilitated, as well asthe relative burden suffered by 
different population subgroups. Consequently, diseases 
and subpopulations that deserve the highest attention 
can be identified.
Burden of Disease in Nepal
The importance of burden of disease estimates for the 
health policy-making process in Nepal becomes evident 
from recent policy documents and recommendations.A 
comprehensive and strategic approach towards public 
health is a relatively recent phenomenon in Nepal. 
The first National Health Policy (NHP) was adopted 
in 1991,3 and served as a policy framework to guide 
the development of the health sector. The NHP was 
mainly focused on increasing the health status of the 
rural population. To this end, it included directives to 
establish health facilities at the Village Development 
Committee level and to implementdecentralization 
throughout the health sector. Based on the NHP, the 
Second Long-Term Health Plan(1997-2017; SLTHP)4 was 
drafted, which was the first document to recognize the 
importance ofprioritizinghealth sector needs, motivated 
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by the scarce human, financial and physical resources 
available. In parallel with the development of the 
SLTHP during the late 90s, a comprehensive analysis 
of health care delivery in Nepal was conducted by the 
World Bank, and in 2000 the results were presented in 
a report entitled Operational Issues and Prioritization 
of Resources in the Health Sector.5  Based on a situation 
analysis, the report makes several recommendations for 
the further development of the Nepalese health sector, 
one of which wasthe establishment of priorities: "Because 
Nepal lacks the institutional or financial capacity to 
do everything that needs to be done immediately, 
health system initiatives and interventions will need 
to be phased in. […] Sequenced priority interventions 
that have the strongest impact on health status need 
to be planned and given the management attention 
and financial resources necessary for their successful 
implementation." These recommendations were carried 
forward in the development of the Nepal Health Sector 
Programmes (NHSP), short-term strategic frameworks 
for the further development of the health sector. Within 
these programmes, disease burden is recognized as 
one of the bases for setting programme priorities. The 
second NHSP Implementation Plan(2010-2015)6 states, 
for example, that the "introduction of new and under-
used vaccines will be prioritised based on disease 
burden, financial sustainability and infrastructure".
But where is the evidence?
Not with standing the importance of burden of disease 
estimates, Nepalese DALY estimates are very scarce. The 
first national burden of disease study was conducted 
by the World Bank in the 90s, and its results appeared 
as an annex to the aforementioned situation analysis 
report.5This study used mortality data from the United 
Mission to Nepal hospitals and morbidity data from WHO 
community-based studies and national vector-borne 
disease control programmes. Data on non-communicable 
diseases (NCDs) were extrapolated from NCD burden of 
disease estimates for rural India.The study estimated a 
national burden of disease for 1996 of 363 DALYs per 
1000 population. The proportion of total DALYs due 
to communicable, maternal/perinatal and nutritional 
condition was 68.5%. Non-communicable and congenital 
diseasesaccounted for 22.8% of the burden, injuries and 
violence for the remaining 8.7%. Based on a decreasing 
fertility rate, the study team projected the national 
burden to decrease to 245 DALYs per 1000 in 2011. 
The proportions of the different disease categories 
were projected to evolve to 61.4%, 28.6% and 10.0%, 
respectively, implying that the group of communicable 
diseases would remain the dominant source of disease 
burden.
A second source of disease burden estimates for Nepal 
is the first update of the WHO Global Burden of Disease 
study.7This study estimated an overall age-standardized 
disease burden of 308 DALYs per 1000 in 2004, in line 
with the World Bank projections. In contrast to the World 
Bank estimates, however, the majority of the burden 
was attributed to non-communicable and congenital 
diseases (48.5%), followed by communicable, maternal/
perinatal and nutritional conditions (39.9%) and injuries 
and violence (11.6%). An important difference between 
the World Bank and WHO studies is that the former 
was largely based on local data, whereas the latter 
was mainly based on regional extrapolations. Except 
for tuberculosis, malaria, HIV/AIDS and childhood-
cluster diseases, the WHO study reported low levels 
of evidence on mortality and morbidity for all other 
considered diseases and disabilities. The cause-of-death 
distribution patterns of India and the Philippines were 
therefore used as proxy for that of Nepal.Although Nepal 
is in certain aspects comparable to these countries, most 
notably India, it is questionable to what extent their 
health situationsare similar. Such extrapolations must 
therefore be treated with caution. It is for instance not 
clear whether or notNepal is undergoing its demographic 
and epidemiological transition at the same pace as 
India. A possible policy shift from communicable to non-
communicable diseases based on these estimates[8], 
should therefore be evaluated with utmost care.
Indeed, the WHO Global Burden of Disease 2004 results 
seem to be refuted by the third and most recent source 
of DALY estimates for Nepal, the comprehensive Global 
Burden of Disease2010 study.[2,9]  This study concludes 
that between 1990 and 2010, the importance of 
communicable diseases has decreased in favour of 
NCDs, but that even today lower respiratory infections, 
diarrheal diseases, and neonatal encephalopathy (due to 
birth asphyxia or trauma) are still the leading causes of 
healthy life years lost in Nepal. However, as GBD2010 
does not provide its raw data, it remains unclear to what 
extent these conclusions were based on local data.
A call for local evidence
It is clear that local and reliable evidence on the burden 
of disease in Nepal is of great importancein setting 
healthcare priorities and monitoring health trends. In 
this respect, it is laudable that national burden of disease 
studies have recently been initiated by the Nepal Health 
Research Council, with the support of the Ministry of 
Health and Population.[10,11] A first Assessment of Burden 
of Diseases in Nepal project was initiated in 2007, and 
was based on a nation-wide sample of primary mortality 
data collected through the Motherhood Method,[12]
and complemented with secondary morbidity data. 
The project is reported to be completed, but results 
have not yet been made available. In 2009, a second 
Assessment of Burden of Diseases in Nepal project was 
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launched, focusing on the Central Development Region 
of Nepal. The main aim of the study is to obtain mortality 
and cause-of-death estimates through verbal autopsy 
questionnaires. This project is currently reported to be 
nearing completion.
Notwithstanding these current efforts, there are still 
huge knowledge gaps with regards to Nepal's health 
status. More and better local information is therefore 
urgently needed. This can and should be achieved at the 
different levels of the data generation process:
There should be an increased focus on basic 
epidemiological research in Nepal. Investments in 
national community-based surveys and longitudinal 
studies would generate new evidence bases upon 
which future policies can be drafted. Nepal is currently 
participating in Demographic and Health Surveys,[13] but 
these surveys only cover a fraction of the entire health 
spectrum, and are mainly focused on child and maternal 
health.
Existing data generation mechanisms should be further 
strengthened. In this respect, the efforts to improve the 
Health Management Information System,[14,15] the official 
hospital-based surveillance system of Nepal,should 
continue to be actively encouraged and supported. 
Capacity strengthening at all levels of the decentralized 
data collection system will need to be an important part 
of these efforts.
Existing data should be made publicly available and 
integrated. The health system in Nepal is multi-
sectorial, with major contributions by private and NGO 
providers, in addition to the government.As a result, 
various government agencies, development partners, 
I/NGOs, local and international academiaare actively 
collecting data, but these are not always made available 
to the general public. Difficulties in obtaining health 
statistics from the private sector has been recognized 
as an important factor limiting the evidence base in 
Nepal.[16]With regards to academic research, improved 
digital thesis libraries could help to disseminate the 
information produced by the various Bachelor, Master 
and PhD students in Nepal.
Available data should be used in the most optimal 
way. Local capacity for transforming the available 
data into policy-relevant information, such as DALYs, 
should therefore be further strengthened. There are 
a number of international projects which can assist in 
the translation of incidence data into burden of disease 
estimates and provide context. These include the 
Global Burden of Disease 2010 Study, which performed 
a comprehensive and consistent revision of disability 
weights, a fundamental input into DALY calculations.
[17] Global and regional estimates of the incidence 
and burden of disease by WHO initiated Epidemiology 
Reference Groups for children (CHERG) and foodborne 
hazards (FERG) can provide issue specific information.[18]
THE WAY FORWARD
By strengthening the local evidence base, we can 
continually improve our understanding of the burden 
of disease in Nepal. By effectively translating this 
evidence into policy, we may furthermore assure that 
this burden can be addressed in the most efficient way.
All stakeholders, including policy makers, development 
partners, researchers and public health workers, should 
therefore join forces to accomplish these goals.
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